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Edited by Christian GriesingerAbstract SH3 domain binding glutamic acid-rich protein like 3
(SH3BGRL3) is the new member of thioredoxin (TRX) super
family, whose posttranslational modiﬁed form was identiﬁed as
tumor necrosis factor a (TNF-a) inhibitory protein, TIP-B1.
In this paper, we determined its solution structure by multi-
dimensional nuclear magnetic resonance spectroscopy. The over-
all structure of human SH3BGRL3 conformed to a TRX-like
fold. To understand its function in vivo, the upregulated expres-
sion in acute promyelocytic leukemia cell line NB4 at both
mRNA and protein level was elucidated. Immunoﬂuorescence
and immunohistochemistry staining with monoclonal antibody
against SH3BGRL3 demonstrated that it was a cytoplasmic pro-
tein in both NB4 cell and human tissues. These results, as a
whole, indicate that SH3BGRL3 may function as a regulator
in all-trans retinoic acid-induced pathway.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Human SH3BGRL3 (SH3 domain binding glutamic acid
rich like protein 3) is a gene identiﬁed recently and mapping
to 1p34.3–35 [1], which belongs to thioredoxin (TRX) superAbbreviations: SH3BGRL3, SH3 domain binding glutamic acid-rich
protein like 3; APL, acute promyelocytic leukemia; ATRA, all-trans
retinoic acid; TNF-a, tumor necrosis factor-a; PMA, phorbol–myris-
tate–acetate; HRP, horseradish peroxidase; NMR, nuclear magnetic
resonance; PAGE, polyacrylamide gel electrophoresis; TRX, thiore-
doxin; TIP, TNF-a inhibitory protein; GAPDH, glyceraldehyde 3-
phosphate dehydrogenase
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doi:10.1016/j.febslet.2005.04.011family. SH3BGRL3 codes for a highly conserved small func-
tionally uncharacterized protein consisting of 93 amino acids.
Like other two family members SH3BGRL [2] and
SH3BGRL2 [3], SH3BGRL3 protein is homologous to N-ter-
minal region of SH3BGR protein. However, lacking the con-
served SH3-binding motif, which exists in SH3BGR and
could also be found in SH3BGRL and SH3BGRL2, implied
that the function of SH3BGRL3 should be quite diﬀerent from
these three proteins. Sequence of SH3BGRL3 shows a signiﬁ-
cant similarity to glutaredoxin 3 of Escherichia coli, but it com-
pletely lacks the conserved consensus sequence (CXXC), which
is essential for glutaredoxin enzymatic activity [1]. The se-
quence of SH3BGRL3 is as same as that of C-terminal domain
of tumor necrosis factor a inhibitory protein (TIP-B1), a TNF-
a inhibitory protein identiﬁed, puriﬁed, and characterized
from cytosolic extracts of TNF-treated human ﬁbroblasts [4].
TIP-B1 protects cells from apoptotic lysis induced by TNF-a
after they were pre-incubated with TIP-B1 [4–7]. Another
study revealed that the SH3BGRL3 gene expression is up reg-
ulated in HL60 cells associated with the diﬀerentiation induced
by phorbol–myristate–acetate (PMA) [8]. These suggested that
the SH3GRL3 might function in the diﬀerentiation related sig-
nal transduction pathway networks.
Acute promyelocytic leukemia (APL) is a speciﬁc type of
acute myeloid leukemia characterized by the t(15; 17) translo-
cation that fuses the PML gene to the retinoic acid receptor a
(RARa) gene on chromosome 17 to form the fusion gene and
leukemogenic protein PML-RARa. It has been demonstrated
that PML-RARa inhibits all-trans retinoic acid (ATRA)-in-
duced diﬀerentiation and contributes to leukemogenesis and
that ATRA could induce the degradation of PML-RARa,
and rescue the blocked diﬀerentiation in APL [9].
Since the function of SH3BGRL3 remains obscure, in this
paper, we report the solution structure of human SH3BGRL3
and speculate the potential binding sites by backbone relaxa-
tion experiments. Structure comparison with other known
structures reveals that it belongs to TRX superfamily, and its
structure is similar to glutaredoxin 3 of E. coli [10] and PICOT
homology domain 2 of PICOT [11]. We also report the regu-
lated expression with ATRA in APL cell line NB4 at both
mRNA and protein level. Our results suggest that SH3BGRL3
may function as a regulator rather than an enzyme in the
ATRA-induced pathway.blished by Elsevier B.V. All rights reserved.
Table 1
NMR structure determination statistics
Distance restraints
Intraresidue (i  j = 0) 265
Sequential (|i  j| = 1) 353
Medium range (2 < |i  j| < 4) 355
Long range (|i  j| > 5) 351
Hydrogen bonds 22
Total 1346
Dihedral angle restraintsa
U 51
W 51
Mean r.m.s.db from the experimental restraints
Distance 0.0131 ± 0.0002
Dihedral 0.1469 ± 0.0191
Mean r.m.s.d. from idealized covalent geometry
Bond 0.0017 ± 0.00004
Angle 0.3208 ± 0.0023
Improper 0.1373 ± 0.0048
Mean energies (kcal mol1)
Etotal 450.66 ± 14.56
Evdw 293.51 ± 9.37
ENOE 26.11 ± 1.76
Eangle 61.42 ± 2.29
Ebond 14.44 ± 1.74
Eimproper 5.02 ± 0.39
Edihedral 0.38 ± 0.13
PROCHECK Ramachandran plot analysis (%)c
Residues in most favored regions 78.9%
Residues in additionally allowed regions 19.8%
Residues in generously allowed regions 0.5%
Residues in disallowed regions 0.8%
Structural r.m.s.d. to the mean coordinatesd (A˚)
Backbone atoms (4–92)d 0.55
Heavy atoms (4–92)d 1.00
aThe U and W angle restraints are generated from secondary structures
by CSI [24].
br.m.s.d., root mean square deviation.
cAll non-Gly residues; U/W of most favored and additional allowed
regions are given by program PROCHECK [32].
dThe unstructured portions of the N- and C-terminal tails were not
considered.
Fig. 1. Solution structure of human SH3BGRL3 protein. (A) Main
chain representation of the 20 lowest energy structures superimposed
on one another. (B) A schematic ribbon representation of SH3BGRL3.
The helices are colored in red and strands are colored in cyan. (C) Two
hydrogen bonds linking b4 to a3. The distances of OD1 of D73 and
HN of D73 and L76 are marked.
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2.1. Cell culture and treatment
Retinoid acic (RA)-sensitive NB4 cells were cultured under condi-
tions previously described [9,12]. The in vitro culture contained
1 lmol/L ATRA. Total RNAs were extracted at indicated time-points
using the Trizol reagent (Invitrogen Inc.) and quality controlled with
Bioanalyzer 2100 capillary electrophoresis (Agilent) prior to the fol-
lowing experiment. Cell diﬀerentiation was evaluated by cell morphol-
ogy changes using Wrights staining, CD11b expression, and the
nitroblue tetrazolium reduction test.
2.2. cDNA microarray
A set of three slides cDNA microarrays covering 12630 genes was
made in Shanghai Biochip and Shanghai Institute of Hematology.
The 40 lg total RNA was labeled with Cy3-(non-treated) or Cy5-(trea-
ted) dCTP (Amersham Biosciences) as reverse transcription incorpora-
tion. The 50 pmol of ﬂuorescence of labeled cDNAs was used as probe
for hybridization and GenePix 4000B ﬂuorescence scanner (Axon Inc.)
was applied in scanning. The ImageQuant (Amersham Biosciences)
and GeneSpring (Silicon Genetics) softwares were applied to analyze
the expression of proper genes, and the normalization was based on
expression level over the whole slides [13].
2.3. Real-time RT-PCR
The expression alteration of the SH3BGRL3 gene was further val-
idated with real-time RT-PCR. The ﬁrst strand cDNA was prepared
with TaqMan Reverse Transcription Reagents (Applied Biosys-
tems, Foster City, CA). The primers were designed with PrimerEx-
press software (Applied Biosystems) and synthesized locally:
F-5 0AGAGCGAGGTGACCCGAAT, R-5 0TGCCAAGGCTCGCA-
TCTC. The GAPDH gene was used as internal control to calculate
expression level with the primers: F-50GAAGGTGAAGGTC-
GGAGTC, R-5 0GAAGATGGTGATGGGATTTC. Real-time PCR
was carried out in an iCycler iQ Real-Time PCR Detection system
(Bio-Rad) using SYBR Green I (Applied Biosystems) as the detec-
tion format. Ampliﬁcation was carried out in a total volume of 25ll
containing 1 · SYBR Green I, 100 nM each primer, 10 nM calibra-
tion dye (Bio-Rad) and 2ll of 1:2 diluted cDNA. The thermal pro-
ﬁle consisted of a 10 min of Taq polymerase activation at 95 C,
followed by 40 cycles of PCR at 95 C for 15 s, 60 C for 1 min.
At the end of the PCR, the temperature was increased 0.5 C every
10 s from 60 to 95 C, and the ﬂuorescence was measured every 10 s
to construct the melting curve. A non-template control was run with
every assay, and all determinations were performed at least in dupli-
cates to achieve reproducibility.
2.4. Recombinant protein expression and puriﬁcation
Human SH3BGRL3 cDNA was obtained from human CD34+
hematopoietic stem/progenitor cell cDNA library, cloned in frame
into pET-22 b (+) in the NdeI/XhoI sites (Novagen) with primers
F-5 0CAGGCTCACATATGAGCGGCCTGCG, R-5 0CTGGGTTA-
CTCGAGAGCCAGCTTCAGGAAC3 0. The recombinant pET-
22b-SH3BGRL3 vector was then transformed into E. coli strain
BL21 (DE3) host cell for expression.
Recombinant human SH3BGRL3 was puriﬁed using Hitrap chelat-
ing column (Amersham Biosciences) chromatography. The puriﬁed re-
combinant protein consists of 101 amino acids, with a C-terminal His
tag (-LEHHHHHH) carried over from the cloning vector. For the
NMR studies, sample of puriﬁed doubly labeled protein was dissolved
to a ﬁnal concentration of 2 mM in 20 mM potassium phosphate (pH
7.0, containing 100 mM NaCl, 1 mM DTT, and 10% D2O). For the
amide proton exchange studies, protein was lyophilized and dissolved
in D2O.
2.5. NMR spectroscopy
All NMR experiments were performed on Bruker DMX500 and
DMX600 spectrometers with self-shielded z-axis gradients at 295 K.
The following spectra were recorded at 295 K to obtain backbone
and side chain resonance assignments: 2D 1H, 15N-HSQC [14], 2D
1H, 13C-HSQC [14], 3D triple-resonance spectra HNCO [15], HN(CA)-
CO [16], CBCA(CO)NH [17], CBCANH [18], C(CO)NH-TOCSY [19],
H(CCO)NH-TOCSY [19], HCCH-TOCSY [20], HCCH-COSY [21],and HBHA(CBCACO)NH [22]. A complete assignment of aromatic
side-chains was facilitated by the identiﬁcation of aromatic d protons
from 2D (HB)CB(CGCD)HD-COSY [23].
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nuclear: Ca, Cb, C 0, and Ha. The derived secondary structures based
on the consensus CSI were converted into restraints on U and W an-
gles: for a-helix residues, U was limited in 60 ± 40 while W was in
50 ± 50; for b-strand residues, U was limited in 120 ± 40 while
W was in 130 ± 50. Hydrogen bond restraints were employed in areas
of regular secondary structures, displaying characteristic NOE cross-
peaks. Each deduced hydrogen bond was represented by two distance
constraints: a-helix residues, 1.6–2.4 A˚ for HN–O and 2.4–3.3 A˚ for
N–O; b-strand residues 1.4–2.7 A˚ for HN–O and 2.4–3.7 A˚ for N–O.
The distance information was collected by 3D 13C separated and
15N-separated NOESY [25] with 130 ms mixing times. NMR data pro-
cessing was carried out using NMRPipe, and the data were analyzed
with SPARKY version 3.106 [26]. Structures were calculated using
the program CNS v1.1 [27], employing a simulated annealing protocol
for torsion angle dynamics [28]. For the initial rounds of structure cal-
culations, only sequential, intraresidual, medium-range NOEs, unam-
biguous long-range NOEs and dihedral angle restraints were used.
Later, all other long-range NOEs and hydrogen bonds were introduced
in consecutive steps. Simple impulsion non-bonded interactions were
used during structure calculation. Twenty structures with the lowest
total energy were selected to form a representative ensemble of the cal-
culated structures.
2.6. 15N relaxation experiments
All 15N relaxation experiments were carried out at 295 K on a Bru-
ker DMX500 NMR spectrometer. 15N relaxation measurements were
carried out using the published methods [29]. 15N T1 relaxation rates
were measured with eight relaxation delays: 11, 62, 142, 243, 364,
525, 757, and 1150 ms. 15N T2 relaxation rates were measured with
six relaxation delays: 17.6, 35.2, 52.8, 70.4, 105.6, and 140.8 ms. A re-
cycle delay of 1 s was used for measurement of T1 and T2 relaxationFig. 2. Structural sequence alignment of (A) isoforms of SH3BGRL3 in diﬀe
sapiens (CAI15827); Mm, Mus musculus (AAH08110); Xl, Xenopus laevis (
(CAG04692). (B) SH3BGRL3, human SH3BGRL3; rTIP-B1p, recombinan
homology domain of PICOT (PDB id: 1WIK). The secondary structure of hum
all ﬁve sequences are colored white in red column and conserved residues ar
observed after 1H–2H exchange experiments are marked at bottom in (A).rates. The spectra measuring 1H–15N NOE were acquired with a 2 s
relaxation delay followed by a 3 s period of proton saturation. The
spectra recorded in the absence of proton saturation employed a relax-
ation delay of 5 s. The exponential curve ﬁtting and extract of T1s and
T2s are processed by SPARKY [26].
2.7. Western blot, immunohistochemistry analysis and cellular
localization
Western blot analysis. The ATRA treated NB4 cell lysates
(50 lg/sample) were separated by 15% Tris–SDS–PAGE (poly-
acrylamide gel electrophoresis) and transferred to Immobilon P
membranes (Millipore) by electroblotting in 25 mM Tris–250 mM
glycine–20% methanol (v/v) (4 C, 90 V, 2 h). The puriﬁed P8E07
IgG3/j isotype mcAb made with rh-SH3BGRL3 was used as pri-
mary antibody, and horseradish peroxidase (HRP)-labeled rabbit-
anti-mouse antibody was as secondary antibody (Cell Signaling
Technology), and the commercial anti-beta actin monoclonal anti-
body (Santa Cruz) was used to evaluate the protein loading amount.
ECL kit (Cell Signaling Technology) was used to develop the results
with X-ray ﬁlm.
Immunohistochemistry. A tissue microarray including 46 normal
representative paraﬃn embedded tissue samples from two accident
available non-diseased human bodies was created with reported pro-
tocol [30] in Shanghai Biochip Center. Staining was revealed with
P8E07 as primary antibody and HRP-conjugated secondary anti-
body using DAKO LASB+ kit (DAKO), following the manufac-
turers instructions.
Cellular localization with immunoﬂuorescence. The NB4 cell treated
with ATRA for 48 h was applied for immunostaining as before [31],
P8E07 to detect the SH3BGRL3, and FITC-labeled rabbit anti-mouse
IgG was used as secondary antibody (Calbiochem). The images were
taken with Axiovert 200 confocal microscope (Bio-Rad).rent organisms. Dashes introduced for maximum alignment. Hs, Homo
AAH68879); Dr, Danio rerio (AAH49323); Tn, Tetraodon nigroviridis
t TIP-B1; GRX, E. coli Glutaredoxin 3; PICOT, the second PICOT
an SH3BGRL3 is indicated above the alignment. Residues identical in
e colored red, while the others are in black. The residues that could be
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3.1. Sequence assignment and NMR determination of human
SH3BGRL3
Complete backbone and nearly complete (>95%) side chain
assignments of residues S2–A93 were made for 1HN, 15N, 1Ha,
1Hb,
13Ca, and 13Cb. In fact, the recombinant protein contains
full length of SH3BGRL3, and an N-terminal Met and a C-ter-
minal his tag, which were not well assigned. All chemical shifts
of the resonance assignments have been deposited in BMRB
(Accession No. 6152).
The root mean square deviation (r.m.s.d.) for the backbone
atoms N, CA, and CO (residues 4–92) was 0.55 A˚ (Fig. 1A)
and for the backbone heavy atoms 1.00 A˚. Structural statistics
is summarized in Table 1.
3.2. Description of the structure
The resulting structure of SH3BGRL3 (PDB ID, 1SJ6)
shares the fold typical to TRX super family [33]. There are four
internal b-sheets (4–8, 36–39, 63–66, and 71–73) and four a-
helices (16–31, 44–54, 74–83, and 85–91). Strands b1 and b2
are parallel, while others are anti-parallel (Fig. 1B). In
1H–2H exchange experiment, it is intriguing that 1HN of Asp
73 and Leu 76 could be observed because their hydrogen bond
donor could not be identiﬁed in the usual way (Fig. 2A) (i.e.,
the hydrogen bonds formed between HN of i + 4 residue and
CO of i residue in a-helix). So restraints of these two H-bonds,
which could be identiﬁed unambiguously by angular orienta-Fig. 3. Structure comparison of one ensemble of solution structure of
human SH3BGRL3 (red) and crystal structure of mouse SH3BGRL3
(blue). The side chains of V11, T12, G13, V14 and I17 are shown. The
distances between OG of Ser14 and HN of 17 are marked, respectively.tions of preliminary structures, were not involved in initial
structure calculation. In NMR structure of SH3BGRL3, HN
of Asp 73 and Leu 76 are hydrogen bonded to OD1 of Asp
73, respectively (Fig. 1C). It is one of the typical capping
box motifs in Ncap involving a hydrogen bond between
OD1 of Asp and HN of N3 (Leu 76) [34]. And Asp73 is con-
served in isoforms of SH3BGRL3 in sequence alignment by
PHI- and PSI-BLAST (Fig. 2).
3.3. Structural comparison of human SH3BGRL3 in solution
and mouse SH3BGRL3 in crystal state
During the preparation of the manuscript, a crystal structure
of mouse SH3BGRL3 was reported [35]. They share 95% iden-
tity in sequence (Fig. 2A). The development supports the sig-
niﬁcance of SH3BGRL3 and provides a good opportunity to
compare crystal and solution structures from independent re-
search. The overall folds of SH3BGRL3 structures determined
by NMR and X-ray crystallography appear to be very similar
(Fig. 3) and the global r.m.s.d. calculated for the backbone
atoms (residues 4–92) of the average secondary structures in
20 structures in solution and the X-ray crystal structure is
0.58 A˚, which is within the precision of the two structure
determinations.
Although solution structure of human SH3BGRL3 and
crystal structure of mouse SH3BGRL3 are very similar, there
are still signiﬁcant diﬀerences existing between them. A classi-
cal type of Ncap interaction in helix involving OG of Ser 14
and HN of Ile 17, which existed in the crystal structure [35],
could not be found in NMR structures for the fast exchange
characteristics of HN of Ile 17 in 1H–2H exchange experiments
(Fig. 3). In structure comparison, the diﬀerence reﬂects the
ﬂexibility of loop linking b1 and a1 in solution. Line broaden-
ing of Gly 13 by averaging chemical shift could be observed in
HSQC, and peaks in other spectra correlated to Gly 13 were
much weaker.
3.4. Structure implication for potential binding sites
In backbone relaxation experiments (in supplementary
material), T2s of S14, E16 (60 ms) and residues between b2Fig. 4. Plots of T2 (ms) as a function of residue number of human
SH3BGRL3. Only residues whose 1H–15N cross-peaks are resolved
enough to permit accurate measurements of their intensities are
included.
Fig. 5. Cellular localization tissue expression distribution of SH3BGRL3. (A) Immunoﬂuorescent image revealed SH3BGRL3 expression in
cytoplasma in NB4 cells. Puriﬁed ascites from P8E07 was used as primary antibody and FITC-labeled rabbit-anti-mouse antibody as secondary
antibody. This cell was treated with ATRA for 48 h. (B) NB4 cell nuclear was stained with Loftan. (C) Integration of (A) and (B) could demonstrate
the cytoplasmic localization in NB4 cell clearly. (D–H) SH3BGRL3 expression in normal tissues, HRP-conjugated goat-anti-mouse IgG was used as
secondary antibody and DAB as colorimetrics in color development. (D) Brain, (E) spleen, (F) trachea, (G) pancreas, (H) esophagus.
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4), combined with peaks of Gly 13 and Arg 15 cannot be ob-
served, which indicates that the loop exhibits a conformational
exchange in solution. In helix a2, no backbone HN exchange
slowly in 1H-2H exchange experiments, which could be ex-
plained as structure breath for binding its partner. Conserved
positive-charged amino acids in helix a1 (Lys 18, Gln 20, and
Gln 21) and a2 (Arg 47 and Arg 51) are notable (Fig. 1B).
Although the partner of SH3BGRL3 remains unknown, relax-
ation experiments, as a whole, suggest that the active sites of
SH3BGRL3 are located on the ﬂexible loop connecting b1–
a1, helix a1, and helix a2. This speculated active-site location
of SH3BGRL3 is consistent with type 1 location in recent re-
port, which is consistent with other TRX-like proteins of
TRX superfamily with known structure [36].
3.5. Subcellular localization and tissue distribution of SH3GRL3
in human
For SH3BGRL3 has no nuclear localization signal, nor
enzymatic activity site at both sequence and structure level,
the subcellular localization could give important hints for its
biological meaning. The monoclonal antibody P8E07 was ap-
plied to map the expression of the nature of SH3BGRL3 in
NB4 and normal human tissues. In NB4 cell, strong cytoplas-
mic signal and almost no nuclear signal was detected by ﬂuo-
rescence microscopy (Fig. 5A–C). In normal human tissues,
SH3BGRL3 protein could be detected in brain, spleen, tra-
chea, pancreas and esophagus with tissue microarray, and re-
vealed to be localized in cytoplasma (Fig. 5D–H).3.6. Expression of SH3BGRL3 in NB4 cells is upregulated and
paralleled with diﬀerentiation induced by all-trans retinoic
acid
NB4 is a representative APL cell line, and the model of dif-
ferentiation induced by ATRA has been well established [9].
Studying the gene expression proﬁling regulation induced by
ATRA in NB4 cells, we identiﬁed the up-regulation of
SH3BGRL3 at mRNA level from early time, and reached
the top after treating with ATRA for 12 h (Fig. 6A), as an
early event [9], and the real-time quantitative RT-PCR could
validate these results (Fig. 6C). Furthermore, Western blot re-
vealed that the protein expression was also up-regulated dur-
ing this course with similar curve, and reached the top at
almost 24 h with 12 h later than gene expression (Fig. 6B). This
strongly paralleled with the diﬀerentiation eﬀect of NB4 [9].4. Discussion
In this paper, we present the solution structure of human
SH3BGRL3 and its regulated expression in APL Cell line
NB4 by ATRA, and we speculate its potential binding site
from its structure similarity and relaxation experiments. Struc-
ture comparison with other known structures reveals that it be-
longs to TRX-like family, and its structure is similar to
glutaredoxin of E. coli [10] and PICOT homology domain 2
of PICOT (PDB 1WIK) [11]. PICOT homology domain also
exists in other organisms as a regulatory domain [11,37].
SH3BGRL3, as well as N-terminal domain of PICOT, lacks
Fig. 6. Expression of SH3BGRL3 in NB4 cells is upregulated and is in
agreement with diﬀerentiation induced by ATRA. (A) cDNA micro-
array results indicated the expression level comparing with the control
NB4 cell RNA, the expression regulation is shown with the ﬂuores-
cence intensity ratios of Cy5 versus Cy3-labeled to test and reference
mRNA, respectively. (B) Western blot analysis of the SH3BGRL3
protein level. The cell lysates were prepared same as in (A). (C) The
real-time RT-PCR analysis of SH3BGRL3 gene expression in NB4
cells. The reaction and cycling conditions are indicated in the text. The
Ct of SH3BGRL3 was normalized with the Ct of GAPDH gene, the
expression level was converted with 2 exp(Ct), and non-ATRA treated
cells were used as reference. The x-axis indicated the ATRA treated
time, and y-axis in (A) and (C) indicated the expression levels
comparing with non-treated cells.
C. Xu et al. / FEBS Letters 579 (2005) 2788–2794 2793the conserved CXXC motif, which is essential for glutaredoxin
enzymatic activity, thus is devoid of the TRX enzyme activity.
PICOT is identiﬁed in human T lymphocytes as a protein ki-
nase C (PKCJ) interacting protein. It plays a negative regula-
tory role in cellular stress response associated with activation
of AP-1 and NF-jB. The interaction between PICOT and
PKC indicates that the TRX enzyme activity is not indispens-
able for the interaction between the PKC superfamily and
TRX system [11]. It has been found that PKC isoforms are in-
volved in PMA-induced and ATRA-induced pathway [38,39].
These give the hint that SH3BGRL3 may function as a regula-
tor rather than an enzyme in the ATRA-induced pathway
through regulating the interaction between TRX system and
PKC superfamily. Further work is required to elucidate its
physiological role and partner in ATRA-induced pathway.
Several members of TNF pathway regulated by ATRA have
been reported; within them, one pathway is related to activa-
tion of NF-jB. Activation of NF-jB inhibits TNF-induced
apoptosis, which could turn on the transcription of genes that
counter the proapoptotic eﬀects of TNF [40]. Posttranslational
modiﬁed SH3BGRL3 could inhibit the cell lysis induced by
TNF-a and play an important role in regulating TNF-induced
cascade reaction [4]. So, the ATRA-induced expression of
SH3BGRL3 may be explained by activation of TNF-inducedNF-jB. This study should provide a basis for further studies
of mechanism of human SH3BGRL3 in ATRA-induced and
TNF-induced pathway.
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